Related Experiment Video
Updated: Jul 16, 2026
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 16, 2010
The endothelial dysfunction in diabetes mellitus
Camelia Pănuş1, Maria Moţa, Delia Vladu
1University of Medicine and Pharmacy, Craiova, Romania.
Insights
Diabetes mellitus leads to vascular complications, primarily due to endothelial dysfunction. Understanding the molecular pathways, like P13 kinase signaling, is key to preventing cardiovascular disease in diabetic patients.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Molecular Biology
Background:
- Vascular endothelial dysfunction is a primary driver of atherosclerosis and a major cause of morbidity and mortality in diabetes mellitus.
- The endothelium, once viewed as a passive lining, is now recognized as a dynamic organ crucial for vascular health and protection against atherosclerosis.
- Impaired endothelial function in diabetes is linked to hyperglycemia, hypertension, dyslipidemia, and hyperglycemia-induced factors, with similar dysfunction observed in insulin-resistant individuals.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying endothelial dysfunction in diabetes mellitus.
- To explore the relationship between metabolic abnormalities and vascular dysfunction at a fundamental level.
- To identify potential therapeutic targets for preventing cardiovascular disease in diabetic patients.
Main Methods:
- Review of current scientific evidence on endothelial function and dysfunction in diabetes.
- Analysis of molecular pathways involved in insulin signaling and nitric oxide (NO) production in endothelial cells.
- Investigation of the role of P13 kinase in mediating insulin's effects on endothelial function.
Main Results:
- Endothelial dysfunction is a critical factor in the vascular complications of diabetes.
- Shared post-receptor pathways, involving P13 kinase, link insulin signaling for glucose transport and NO production in the endothelium.
- Metabolic and vascular abnormalities are fundamentally interconnected, as evidenced by endothelial dysfunction in insulin-resistant individuals.
Conclusions:
- Understanding the molecular pathogenesis of endothelial dysfunction is crucial for developing novel strategies to treat and prevent cardiovascular disease in diabetes mellitus.
- Targeting the P13 kinase pathway may offer a promising therapeutic approach.
- The intricate relationship between metabolic health and vascular integrity underscores the importance of comprehensive diabetes management.
Abstract:
The vascular chronic complications are the main cause of morbidity and mortality in patients with diabetes mellitus. Nowadays it is well known the fact that the arteriosclerosis is initiated by the injury of the vascular endothelium and that the normal endothelial cells are producing a number of vasoactive factors. Thus, the vascular endothelium was considered an inert "lining" layer, but today is seen as a complex organ, with paracrin and autocrin function, which provides a "first line" physiological defence against atherosclerosis. Impaired endothelial function occurs in people with diabetes as a result of associated conditions (e.g. hyperglycemia, hypertension, dyslipidemia), or as an effect of hyperglycemia itself (e.g. cytokines, free fatty acids, AGES). The presence of endothelial dysfunction in non diabetic insulin resistant subjects suggests that metabolic and vascular abnormalities are tightly related at a fundamental level. Recent evidence suggests that insulin signalling for glucose transport in classical target tissues (muscle and adipose tissue) and upregulation of NO production in the endothelium utilises the same postreceptor pathway. This pathway involves the enzyme P13 kinase. Knowledge of the molecular mechanisms involved in the pathogenesis of endothelial dysfunction may ultimately result in novel approaches to the treatment and prevention of cardiovascular disease in people with diabetes mellitus.
More Related Videos
Related Concept Videos
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Type I Diabetes II: Pathophysiology
01:24Type II Diabetes II: Pathophysiology
01:27Diabetic Retinopathy
01:28Diabetic Nephropathy
01:22Diabetic Neuropathy